Comparison of two-dose priming plus 9-month booster with a standard three-dose priming schedule for a ten-valent pneumococcal conjugate vaccine in Nepalese infants: a randomised, controlled, open-label, non-inferiority trial.

Hamaluba, M; Kandasamy, R; Upreti, S; Subedi, G; Shrestha, S; Bhattarai, S; Gurung, M; Pradhan, R; Voysey, M; Gurung, S; Pradhan, S; Thapa, A; Maharjan, R; Kiran, U; Kerridge, S; Hinds, J; van der Klis, F; Snape, M; Murdoch, D; Kelly, S; Kelly, D; Adhikari, N; Thorson, S; Pollard, A

Journal article

Comparison of two-dose priming plus 9-month booster with a standard three-dose priming schedule for a ten-valent pneumococcal conjugate vaccine in Nepalese infants: a randomised, controlled, open-label, non-inferiority trial.

Abstract:: BACKGROUND: Use of pneumococcal conjugate vaccines (PCVs) in resource-poor countries has focused on early infant immunisation with little emphasis on protection in late infancy and beyond. Boosting of the immune response later in infancy might provide improved persistence of immunogenicity into early childhood, however data are scarce. The aim of this study was to investigate if a two-dose prime with booster at age 9 months compared with a three-dose prime-only PCV schedule provided non-infer...
Expand abstract
Collapse abstract

Publication status:: Published

Peer review status:: Peer reviewed

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Cite

Cite this record

APA Style

Hamaluba, M., Kandasamy, R., Upreti, S., Subedi, G., Shrestha, S., Bhattarai, S., Gurung, M., Pradhan, R., Voysey, M., Gurung, S., Pradhan, S., Thapa, A., Maharjan, R., Kiran, U., Kerridge, S., Hinds, J., van der Klis, F., Snape, M., Murdoch, D., … Pollard, A. (2015). Comparison of two-dose priming plus 9-month booster with a standard three-dose priming schedule for a ten-valent pneumococcal conjugate vaccine in Nepalese infants: a randomised, controlled, open-label, non-inferiority trial. Lancet. Infectious Diseases, 15(4), 405–414.

MLA Style

Hamaluba, M., et al. “Comparison of Two-Dose Priming plus 9-Month Booster with a Standard Three-Dose Priming Schedule for a Ten-Valent Pneumococcal Conjugate Vaccine in Nepalese Infants: a Randomised, Controlled, Open-Label, Non-Inferiority Trial.” Lancet. Infectious Diseases, vol. 15, no. 4, Elsevier, 2015, pp. 405–14.

Chicago Style

Hamaluba, M, R Kandasamy, S Upreti, G Subedi, S Shrestha, S Bhattarai, M Gurung, et al. 2015. “Comparison of Two-Dose Priming plus 9-Month Booster with a Standard Three-Dose Priming Schedule for a Ten-Valent Pneumococcal Conjugate Vaccine in Nepalese Infants: a Randomised, Controlled, Open-Label, Non-Inferiority Trial.” Lancet. Infectious Diseases 15 (4): 405–14.
Tweet
Print